# FOXO6

## Overview
FOXO6 is a gene that encodes the forkhead box O6 protein, a member of the FOXO family of transcription factors. These proteins are characterized by a conserved forkhead DNA-binding domain, which is crucial for their role in regulating gene expression. The FOXO6 protein is predominantly expressed in the central nervous system, muscle, and liver, where it plays a significant role in processes such as synaptic function, memory consolidation, and oxidative stress response (Link2018Introduction; Salih2012FoxO6). Unlike other FOXO proteins, FOXO6 lacks a carboxy terminal AKT phosphorylation site, which influences its regulatory mechanisms (Tzivion2011FoxO). The protein's unique structural features, including the absence of a nuclear export signal, allow it to remain in the nucleus and interact with DNA, thereby influencing various metabolic and developmental processes (Santos2023FOXO).

## Structure
The FOXO6 protein is a member of the FOXO transcription factors, characterized by a conserved forkhead DNA-binding domain. This domain is a winged-helix motif consisting of three alpha-helices, three beta-strands, and two wing-like loops, which is crucial for DNA binding (Singh2017Crystal; van2011The). The FOXO6 protein shares structural similarities with other FOX family proteins, particularly in the forkhead domain, which is under strong evolutionary constraints (Wang2009FoxO).

FOXO6 is subject to post-translational modifications, including phosphorylation, which affects its stability and activity. Unlike other FOXO proteins, FOXO6 lacks the carboxy terminal AKT phosphorylation site, which is a common feature in other FOXO family members (Tzivion2011FoxO). Phosphorylation events are crucial for the regulation of FOXO proteins, influencing their subcellular localization and interactions with other proteins (van2007Stressing).

The FOXO6 protein is predominantly expressed in the central nervous system, muscle, and liver, suggesting a role in regulating specific physiological processes in these tissues (Link2018Introduction). However, detailed information on the primary, secondary, tertiary, or quaternary structures, as well as splice variant isoforms of FOXO6, is not provided in the available literature.

## Function
FOXO6 is a transcription factor that plays a significant role in regulating gene expression related to synaptic function, memory consolidation, and oxidative stress response. It is predominantly expressed in the central nervous system, particularly in the hippocampus, where it is crucial for memory processes. FOXO6 regulates genes involved in synapse formation, glutamate signaling, and the p53 pathway, which are essential for synaptic connectivity and neuronal stress responses (Salih2012FoxO6).

In the hippocampus, FOXO6 influences the expression of genes that coordinate synaptic number and function, contributing to memory consolidation by maintaining proper neuronal connectivity (Salih2012FoxO6). FOXO6 deficiency leads to decreased dendritic spine density, indicating its role in synaptic plasticity and memory encoding (Salih2012FoxO6).

FOXO6 also plays a role in managing oxidative stress by regulating antioxidant genes such as MnSOD and catalase, which help control intracellular oxidative stress levels. This function is particularly relevant in the context of skin aging and melanogenesis, where FOXO6 activity decreases with age and UV exposure, leading to increased oxidative stress (Moon2020FoxO6).

## Clinical Significance
Mutations and alterations in the expression of the FOXO6 gene have been implicated in several diseases and conditions. In the context of neurodegenerative diseases, FOXO6 is involved in regulating genes associated with synaptic function and memory consolidation. Dysregulation of these genes, such as those involved in glutamate signaling and the p53 pathway, is linked to Alzheimer's disease. This suggests that FOXO6 may play a role in the cognitive decline observed in Alzheimer's patients (Salih2012FoxO6).

FOXO6 is also associated with breast cancer risk. A study identified a specific single-nucleotide polymorphism (SNP), rs61229336, in the FOXO6 gene that is significantly associated with breast cancer. This SNP is linked to decreased mRNA expression levels of FOXO6, suggesting a potential role in tumorigenesis. The study indicates that FOXO6 may act as an oncogene in breast cancer, although the exact mechanisms remain unclear (Wang2021Association).

Overall, alterations in FOXO6 expression or function can impact memory and cognitive processes, potentially contributing to age-related cognitive disorders and cancer. Further research is needed to fully understand the biological mechanisms underlying these associations.

## Interactions
FOXO6 is a transcription factor that participates in various interactions with proteins and nucleic acids, influencing metabolic and developmental processes. In the liver, FOXO6 binds to the promoter of the microsomal triglyceride transfer protein (MTP), enhancing its expression and thereby increasing very low-density lipoprotein-triglyceride (VLDL-TG) production. This interaction is inhibited by insulin, which phosphorylates FOXO6, preventing its binding to the MTP promoter (Kim2014FoxO6). FOXO6 also interacts with peroxisome proliferator-activated receptor gamma (PPAR-γ), stimulating its expression and activity, which promotes lipogenesis and fat accumulation in the liver (Kim2014FoxO6).

In the context of craniofacial development, FOXO6 regulates the Hippo signaling pathway by directly interacting with the Lats1 promoter, which affects cell proliferation and craniofacial growth. This interaction is crucial for the modulation of craniofacial morphology and development (Sun2018FoxO6). FOXO6's unique structural features, such as the absence of a nuclear export signal, allow it to remain in the nucleus and interact with DNA, unlike other FOXO isoforms that translocate to the cytoplasm upon phosphorylation (Santos2023FOXO).


## References


[1. (Wang2009FoxO) Minghui Wang, Xiangzhe Zhang, Hongbo Zhao, Qishan Wang, and Yuchun Pan. Foxo gene family evolution in vertebrates. BMC Evolutionary Biology, 9(1):222, 2009. URL: http://dx.doi.org/10.1186/1471-2148-9-222, doi:10.1186/1471-2148-9-222. This article has 32 citations.](https://doi.org/10.1186/1471-2148-9-222)

[2. (van2007Stressing) Armando van der Horst and Boudewijn M.T. Burgering. Stressing the role of foxo proteins in lifespan and disease. Nature Reviews Molecular Cell Biology, 8(6):440–450, June 2007. URL: http://dx.doi.org/10.1038/nrm2190, doi:10.1038/nrm2190. This article has 593 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm2190)

[3. (Link2018Introduction) Wolfgang Link. Introduction to FOXO Biology, pages 1–9. Springer New York, November 2018. URL: http://dx.doi.org/10.1007/978-1-4939-8900-3_1, doi:10.1007/978-1-4939-8900-3_1. This article has 104 citations.](https://doi.org/10.1007/978-1-4939-8900-3_1)

[4. (Salih2012FoxO6) Dervis A.M. Salih, Asim J. Rashid, Damien Colas, Luis de la Torre-Ubieta, Ruo P. Zhu, Alexander A. Morgan, Evan E. Santo, Duygu Ucar, Keerthana Devarajan, Christina J. Cole, Daniel V. Madison, Mehrdad Shamloo, Atul J. Butte, Azad Bonni, Sheena A. Josselyn, and Anne Brunet. Foxo6 regulates memory consolidation and synaptic function. Genes &amp; Development, 26(24):2780–2801, December 2012. URL: http://dx.doi.org/10.1101/gad.208926.112, doi:10.1101/gad.208926.112. This article has 105 citations.](https://doi.org/10.1101/gad.208926.112)

[5. (van2011The) Kristan E. van der Vos and Paul J. Coffer. The extending network of foxo transcriptional target genes. Antioxidants &amp; Redox Signaling, 14(4):579–592, February 2011. URL: http://dx.doi.org/10.1089/ars.2010.3419, doi:10.1089/ars.2010.3419. This article has 188 citations.](https://doi.org/10.1089/ars.2010.3419)

[6. (Singh2017Crystal) Puja Singh, Eun Hee Han, James A. Endrizzi, Richard M. O’Brien, and Young-In Chi. Crystal structures reveal a new and novel foxo1 binding site within the human glucose-6-phosphatase catalytic subunit 1 gene promoter. Journal of Structural Biology, 198(1):54–64, April 2017. URL: http://dx.doi.org/10.1016/j.jsb.2017.02.006, doi:10.1016/j.jsb.2017.02.006. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jsb.2017.02.006)

[7. (Wang2021Association) Haijiao Wang, Hongliang Liu, Lingling Zhao, Sheng Luo, Tomi Akinyemiju, Shelley Hwang, Ying Yue, and Qingyi Wei. Association of genetic variants of fbxo32 and foxo6 in the foxo pathway with breast cancer risk. Molecular Carcinogenesis, 60(10):661–670, July 2021. URL: http://dx.doi.org/10.1002/mc.23331, doi:10.1002/mc.23331. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/mc.23331)

[8. (Santos2023FOXO) Bruno F. Santos, Inês Grenho, Paulo J. Martel, Bibiana I. Ferreira, and Wolfgang Link. Foxo family isoforms. Cell Death &amp; Disease, October 2023. URL: http://dx.doi.org/10.1038/s41419-023-06177-1, doi:10.1038/s41419-023-06177-1. This article has 12 citations.](https://doi.org/10.1038/s41419-023-06177-1)

[9. (Sun2018FoxO6) Zhao Sun, Clarissa S. G. da Fontoura, Myriam Moreno, Nathan E. Holton, Mason Sweat, Yan Sweat, Myoung Keun Lee, Jed Arbon, Felicitas B. Bidlack, Daniel R. Thedens, Peggy Nopoulos, Huojun Cao, Steven Eliason, Seth M. Weinberg, James F. Martin, Lina Moreno-Uribe, and Brad A. Amendt. Foxo6 regulates hippo signaling and growth of the craniofacial complex. PLOS Genetics, 14(10):e1007675, October 2018. URL: http://dx.doi.org/10.1371/journal.pgen.1007675, doi:10.1371/journal.pgen.1007675. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1007675)

[10. (Moon2020FoxO6) Kyoung Mi Moon, Bonggi Lee, Dae Hyun Kim, and Hae Young Chung. Foxo6 inhibits melanogenesis partly by elevating intracellular antioxidant capacity. Redox Biology, 36:101624, September 2020. URL: http://dx.doi.org/10.1016/j.redox.2020.101624, doi:10.1016/j.redox.2020.101624. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.redox.2020.101624)

[11. (Tzivion2011FoxO) Guri Tzivion, Melissa Dobson, and Gopalakrishnan Ramakrishnan. Foxo transcription factors; regulation by akt and 14-3-3 proteins. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1813(11):1938–1945, November 2011. URL: http://dx.doi.org/10.1016/j.bbamcr.2011.06.002, doi:10.1016/j.bbamcr.2011.06.002. This article has 539 citations.](https://doi.org/10.1016/j.bbamcr.2011.06.002)

[12. (Kim2014FoxO6) Dae Hyun Kim, Ting Zhang, Sojin Lee, Virtu Calabuig-Navarro, Jun Yamauchi, Ann Piccirillo, Yong Fan, Radha Uppala, Eric Goetzman, and H. Henry Dong. Foxo6 integrates insulin signaling with mtp for regulating vldl production in the liver. Endocrinology, 155(4):1255–1267, April 2014. URL: http://dx.doi.org/10.1210/en.2013-1856, doi:10.1210/en.2013-1856. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/en.2013-1856)